Related Experiment Videos
Specific targeting of human papillomavirus type 16 E7 oncogene with triple-helix forming purine
Abstract:
Molecular mechanical calculations (computer modelling), optical DNA melting experiments and co-migration assay were used to assess stable helix formation at homopurine-homopyrimidine-rich target sites present in the human papillomavirus type 16 E7 oncogene (positions 656-673 on the genome map). The target sequence, either present in the E7 oncogene obtained by PCR technique or prepared from oligodeoxyribonucleotides (ODNs), can be specifically recognised by different 17-merpurine ODNs designed to form antiparallel or parallel triple helices. These "in vitro" experiments realised with rather long purine ODNs having a high degree of specificity, open the way for "in vivo" tests focused on E7 oncogene targeting and suppression.
Insights
Researchers used computer modeling and DNA experiments to show that specific DNA sequences in the human papillomavirus type 16 E7 oncogene can form stable triple helices. This finding supports future in vivo studies for targeting and suppressing the E7 oncogene.
Area of Science:
- Molecular biology
- Biophysics
- Computational chemistry
Background:
- The human papillomavirus type 16 (HPV16) E7 oncogene is a key factor in cervical cancer development.
- Targeting oncogenes offers a potential strategy for cancer therapy.
- Understanding DNA structural dynamics is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the formation of stable DNA triple helices at specific sites within the HPV16 E7 oncogene.
- To assess the potential of oligodeoxyribonucleotides (ODNs) to target and bind to these sites.
- To lay the groundwork for in vivo applications aimed at E7 oncogene suppression.
Main Methods:
- Utilized molecular mechanical calculations (computer modeling) to simulate DNA interactions.
- Performed optical DNA melting experiments to analyze helix stability.
- Employed co-migration assays to study DNA-ODN interactions.
- Generated target sequences using PCR and synthesized oligodeoxyribonucleotides (ODNs).
Main Results:
- Demonstrated stable triple helix formation at homopurine-homopyrimidine-rich target sites (positions 656-673) in the HPV16 E7 oncogene.
- Showcased specific recognition and binding of designed 17-mer purine ODNs to the target sequences.
- Confirmed the ability of ODNs to form both antiparallel and parallel triple helices with the target DNA.
Conclusions:
- Stable DNA triple helix formation is achievable at specific oncogene sites using designed ODNs.
- These in vitro findings provide a strong foundation for in vivo studies targeting the HPV16 E7 oncogene.
- The high specificity of long purine ODNs suggests potential for therapeutic applications in suppressing oncogene activity.